The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Changes in Androgen Receptor Nongenotropic Signaling Correlate with Transition of LNCaP Cells to Androgen Independence
Open accessAbstract
A cure for prostate cancer (CaP) will be possible only after a complete understanding of the mechanisms causing this disease to progress from androgen dependence to androgen independence. To carry on a careful characterization of the phenotypes of CaP cell lines before and after acquisition of androgen independence, we used two human CaP LNCaP sublines: LNCaPnan, which is androgen dependent (AD), and LNCaP-HP, which is androgen independent (AI). In AD LNCaPnan cells, dihydrotestosterone (DHT) stimulated in an androgen receptor (AR)-dependent way a phosphorylation signaling pathway involving steroid receptor coactivator (Src)–mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase (MEK)-1/2–ERK-1/2–cAMP-response element binding-protein (CREB). Activation of this pathway was associated with increased [3H]thymidine incorporation and resistance to apoptosis. Use of dominant-negative forms of MEK-1/2 and CREB demonstrated in LNCaPnan cells that DHT induced [3H]thymidiine incorporation through a thus far unidentified molecule activated downstream of MEK-1/2, and antiapoptosis through phosphorylation of the transcription factor CREB. In contrast, in AI LNCaP-HP cells, the Src–MEK-1/2–ERK-1/2–CREB pathway was constitutively active. Because it was not further stimulated by addition of DHT, no increase of [3H]thymidine incorporation or apoptosis resistance was demonstrated in LNCaP-HP cells. Additional experiments showed that Src and the scaffold protein MNAR coimmunoprecipitated with AR, indicating a role for Src as an apical molecule in the Src–MEK-1/2–ERK-1/2–CREB pathway. Interestingly, differences between the two cell lines were that in LNCaP-HP cells presence of an AI phenotype and lack of response to DHT were associated with constitutive activation of the protein kinase Src and interaction among Src, AR, and MNAR. In contrast, in LNCaPnan cells, presence of an AD phenotype and ability to respond to DHT were associated with DHT-dependent activation of Src kinase activity and interaction among Src, AR, and MNAR. Intriguingly, in LNCaPnan cells, we found that transcription through the prototypical CREB-responsive promoter c-fos could be induced in a DHT-dependent way, and this action was inhibited by the AR antagonist Casodex and MEK-1 inhibitor PD98059. In contrast, transcription through the PSA P/E promoter, a prototypical AR-dependent promoter directly activated by agonist, was obliterated only by Casodex. Additional experiments with genital skin fibroblasts derived from patients with a variety of AR abnormalities indicated that nongenotropic AR signaling does not depend on an intact DNA-binding domain or on the ability of AR to translocate to the nucleus. The results suggest the following: (1) Constitutive activation of the Src–MEK-1/2–ERK-1/2–CREB pathway is associated with the AI phenotype observed in LNCaP-HP cells. (2) Activation of the Src–MEK-1/2–ERK-1/2–CREB pathway is DHT dependent in AD LNCaPnan cells. (3) DHT activation of this pathway is associated with induction of [3H]thymidine incorporation by a molecule activated downstream of MEK-1/2 and of antiapoptosis through activation of the transcription factor CREB in AD LNCaPnan cells. (4) AR regulates transcription either directly upon ligand binding and nuclear translocation or indirectly through kinase pathways leading to activation of downstream transcription factors. (5) Nuclear translocation and ability of the DNA-binding domain of AR to interact with DNA are not prerequisites for nongenotropic AR activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
Molecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278
Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.
Eisenberger, M. A., Blumenstein, B. A., Crawford, E. D., Miller, G., McLeod, D. G., Loehrer, P. J., Wilding, G., Sears, K., Culkin, D. J., Thompson, I. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391504 · Cited by 859
The Androgen Axis in Recurrent Prostate Cancer
Mohler, J. L., Gregory, C. W., Ford, O. H., Kim, D., Weaver, C. M., Petrusz, P., Wilson, E. M., & French, F. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1146-03 · Cited by 675
Activating SRC mutation in a subset of advanced human colon cancers
Irby, R. B., Mao, W., Coppola, D., Kang, J., Loubeau, J. M., Trudeau, W., Karl, R., Fujita, D. J., Jove, R., & Yeatman, T. J. (1999) · Nature Genetics · doi:10.1038/5971 · Cited by 489
Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.
Talamonti, M. S., Roh, M. S., Curley, S. A., & Gallick, G. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116200 · Cited by 399
Steroid 5α-Reductase 2 Deficiency*
WILSON, J. D., GRIFFIN, J. E., & RUSSELL, D. W. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-5-577 · Cited by 346
pp60c-src activation in human colon carcinoma.
Cartwright, C. A., Kamps, M. P., Meisler, A. I., Pipas, J. M., & Eckhart, W. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114113 · Cited by 265
Research works printed but not linked: 61
- Cato AC, Nestl A, Mink S Rapid actions of steroid receptors in cellular signaling pathways. Sci Signal Transduction Knowledge Environment 2002;2002:RE9 · doi:10.1126/scisignal.1382002re9 · Paper page
- Szego CM, Davis JS Adenosine 3′,5′-monophosphate in rat uterus: acute elevation by estrogen. Proc Natl Acad Sci USA 1967;58:1711-8. · DOI · Paper page
- Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M Multiple actions of steroid hormones: a focus on rapid, nongenomic effects. Pharmacol Rev 2000;52:513-56.
- Li X, Qiu J, Wang J, Zhong Y, Zhu J, Chen Y Corticosterone-induced rapid phosphorylation of p38 and JNK mitogen-activated protein kinases in PC12 cells. FEBS Lett 2001;492:210-4. · DOI
- Haseroth K, Gerdes D, Berger S, et al Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice. Biochem Biophys Res Commun 1999;266:257-61. · DOI
- Migliaccio A, Di Domenico M, Castoria G, et al Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996;15:1292-300. · DOI · Paper page
- Razandi M, Pedram A, Greene GL, Levin ER Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol 1999;13:307-19. · DOI · Paper page
- Migliaccio A, Piccolo D, Castoria G, et al Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 1998;17:2008-18. · DOI · Paper page
- Boonyaratanakornkit V, Scott MP, Ribon V, et al Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 2001;8:269-80. · DOI · Paper page
- Peterziel H, Mink S, Schonert A, Becker M, Klocker H, Cato AC Rapid signalling by androgen receptor in prostate cancer cells. Oncogene 1999;18:6322-9. · DOI · Paper page
- Migliaccio A, Castoria G, Di Domenico M, et al Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation. EMBO J 2000;19:5406-17. · DOI · Paper page
- Kousteni S, Bellido T, Plotkin LI, et al Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001;104:719-30. · DOI · Paper page
- Lutz LB, Jamnongjit M, Yang WH, Jahani D, Gill A, Hammes SR Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol Endocrinol 2003;17:1106-16. · DOI
- Kousteni S, Han L, Chen JR, et al Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Investig 2003;111:1651-64. · DOI
- Kousteni S, Chen JR, Bellido T, et al Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 2002;298:843-6. · DOI · Paper page
- Zhu Y, Bond J, Thomas P Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 2003;100:2237-42. · DOI · Paper page
- Zhu Y, Rice CD, Pang Y, Pace M, Thomas P Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA 2003;100:2231-6. · DOI · Paper page
- McPhaul MJ, Marcelli M, Zoppi S, Griffin JE, Wilson JD Genetic basis of endocrine disease: 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metab 1993;76:17-23. · doi:10.1210/jcem.76.1.8421085 · Paper page
- Kyprianou N, Isaacs J Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 1988;122:552-62. · DOI · Paper page
- Pollard M, Luckert PH, Sporn MB Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res 1991;51:3610-1.
- Wu J-P, Fang-Liu G The prostate 41–65 years post-castration, an analysis of 26 eunuchs. Chin Med J 1987;100:271-2.
- Stanbrough M, Leav I, Kwan PW, Bubley GJ, Balk SP Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium. Proc Natl Acad Sci USA 2001;98:10823-8. · DOI · Paper page
- Kazemi-Esfarjani P, Trifiro MA, Pinsky L Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet 1995;4:523-7. · DOI · Paper page
- Giovannucci E, Stampfer MJ, Krithivas K, et al The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1997;94:3320-3.Erratum in: Proc Natl Acad Sci USA 1997;94:8272 · DOI · Paper page
- Hardy DO, Scher HI, Bogenreider T, et al Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab 1996;81:4400-5. · doi:10.1210/jcem.81.12.8954049 · Paper page
- Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 2002;62:1008-13.
- Craft N, Shostak Y, Carey M, Sawyers C A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 1999;5:280-5. · DOI · Paper page
- Marcelli M, Ittmann M, Mariani M, et al Androgen receptor mutations in prostate cancer. Can Res 2000;60:944-9.
- Nazareth L, Weigel N Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem 1996;271:19900-7. · DOI · Paper page
- Culig Z, Hobish A, Cronauer MV, et al Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 1994;54:5474-8.
- Gregory CW, He B, Johnson RT, et al A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 2001;61:4315-9.
- Avila DM, Wilson CM, Nandi N, Griffin JE, McPhaul MJ Immunoreactive AR and genetic alterations in subjects with androgen resistance and undetectable AR levels in genital skin fibroblast ligand-binding assays. J Clin Endocrinol Metab 2002;87:182-8. · doi:10.1210/jcem.87.1.8166
- Zoppi S, Marcelli M, Deslypere J-P, Griffin JE, Wilson JD, McPhaul MJ Amino acid substitution in the DNA binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance. Mol Endocrinol 1992;6:409-15. · DOI
- Wilson CM, Griffin JE, Wilson JD, Marcelli M, Zoppi S, McPhaul MJ Immunoreactive androgen receptor expression in subjects with androgen resistance. J Clin Endocrinol Metab 1992;75:1474-8. · DOI
- Kim DW, Cheriyath V, Roy AL, Cochran BH TFII-I enhances activation of the c-fos promoter through interactions with upstream elements. Mol Cell Biol 1998;18:3310-20. · DOI
- Mansour SJ, Matten WT, Hermann AS, et al Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 1994;265:966-70. · DOI · Paper page
- Jean D, Harbison M, McConkey DJ, Ronai Z, Bar-Eli M CREB and its associated proteins act as survival factors for human melanoma cells. J Biol Chem 1998;273:24884-90. · DOI · Paper page
- Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 2002;99:14783-8. · DOI · Paper page
- Janik P, Briand P, Hartmann NR The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. Cancer Res 1975;35:3698-704.
- Mayr B, Montminy M Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001;2:599-609. · DOI · Paper page
- Cooper JA, Esch FS, Taylor SS, Hunter T Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro. J Biol Chem 1984;259:7835-41. · DOI · Paper page
- Marcelli M, Haidacher SJ, Plymate SR, Birnbaum RS Altered growth and insulin-like growth factor binding protein-3 (IGFBP-3) production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor cDNA. Endocrinology 1995;136:1040-8. · DOI
- Raffo A, Perlman H, Chen M-W, Day M, Streitman J, Buttyan R Overexpression of bcl-2 protects cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 1995;55:4438-45.
- Xing J, Ginty DD, Greenberg ME Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 1996;273:959-63. · DOI · Paper page
- De Cesare D, Jacquot S, Hanauer A, Sassone-Corsi P Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci USA 1998;95:12202-7. · DOI · Paper page
- Marcelli M, Cunningham G, Walkup M, et al Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: overexpression of caspase-7 as a new gene therapy strategy for the treatment of prostate cancer. Cancer Res 1999;59:398-406.
- Tilley WD, Marcelli M, Wilson JD, McPhaul JM Characterization and cloning of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci USA 1989;86:327-31. · DOI · Paper page
- Krishnan AV, Zhao XY, Swami S, et al A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer. Endocrinology 2002;143:1889-900. · doi:10.1210/endo.143.5.8778
- Castoria G, Lombardi M, Barone MV, et al Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J Cell Biol 2003;161:547-56. · DOI
- Muthuswamy SK, Siegel PM, Dankort DL, Webster MA, Muller WJ Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol Cell Biol 1994;14:735-43. · DOI
- Rosen N, Bolen JB, Schwartz AM, et al Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. J Biol Chem 1986;261:13754-9. · DOI · Paper page
- Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, et al Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res 1992;52:4773-8.
- Egan C, Pang A, Durda D, Cheng HC, Wang JH, Fujita DJ Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530. Oncogene 1999;18:1227-37. · DOI
- Gioeli D, Mandell JW, Petroni GR, Frierson HF, Jr, Weber MJ Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res 1999;59:279-84.
- Price DT, Rocca GD, Guo C, Ballo MS, Schwinn DA, Luttrell LM Activation of extracellular signal-regulated kinase in human prostate cancer. J Urol 1999;162:1537-42. · doi:10.1016/s0022-5347(05)68354-1
- Bakin RE, Gioeli D, Sikes RA, Bissonette EA, Weber MJ Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells. Cancer Res 2003;63:1981-9.
- Bakin RE, Gioeli D, Bissonette EA, Weber MJ Attenuation of Ras signaling restores androgen sensitivity to hormone-refractory C4–2 prostate cancer cells. Cancer Res 2003;63:1975-80.
- Voeller H, Wilding G, Gelmann E v-rasH expression confers hormone-independent in-vitro growth to LnCAP prostate carcinoma cells. Mol Endocrinol 1991;5:209-16. · DOI
- Foulkes NS, Sassone-Corsi P Transcription factors coupled to the cAMP-signalling pathway. Biochim Biophys Acta 1996;1288:F101-21. · DOI
- Iordanov M, Bender K, Ade T, et al CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. EMBO J 1997;16:1009-22. · DOI · Paper page
- Rowan BG, Weigel NL, O’Malley BW Phosphorylation of steroid receptor coactivator-1: identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J Biol Chem 2000;275:4475-83. · DOI · Paper page
Cited by
Androgen Receptor Structure, Function and Biology: From Bench to Bedside.
(2016) · Europe PMC (PubMed Central) · Cited by 623
Non-genomic actions of androgens
Foradori, C. D., Weiser, M. J., & Handa, R. J. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.10.005 · Cited by 493
Extranuclear Steroid Receptors: Nature and Actions
Hammes, S. R., & Levin, E. R. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0022 · Cited by 475
FSH and testosterone signaling in Sertoli cells
Walker, W. H., & Cheng, J. (2005) · Reproduction · doi:10.1530/rep.1.00358 · Cited by 467
A Conserved Mechanism for Steroid Receptor Translocation to the Plasma Membrane
Pedram, A., Razandi, M., Sainson, R. C. A., Kim, J. K., Hughes, C. C., & Levin, E. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611877200 · Cited by 446
Metadata
- Authors
- Unni, E., Sun, S., Nan, B., McPhaul, M. J., Cheskis, B., Mancini, M. A., & Marcelli, M.
- Venue
- Cancer Research
- Published
- 2004-10-01
- Volume
- 64
- Issue
- 19
- Pages
- 7156-7168
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2117638862
- Cited by
- 229
- References
- 9
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changes in Androgen Receptor Nongenotropic Signaling Correlate with Transition of LNCaP Cells to Androgen Independence. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-1121
- The paper
- Unni, E., Sun, S., Nan, B., McPhaul, M. J., Cheskis, B., Mancini, M. A., & Marcelli, M. (2004). Changes in Androgen Receptor Nongenotropic Signaling Correlate with Transition of LNCaP Cells to Androgen Independence. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-1121
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.